Amgen And AbbVie In Legal Settlement
socalTECH
SEPTEMBER 28, 2017
Thousand Oaks-based Amgen and AbbVie have settled a series of lawsuits against each other, saying this morning that they have agreed to resolve all pending litigation regarding AMGEVITA/AMJEVITA, a biosimilar which is based on AbbVie's Humira (adalimumab). The two have also agreed to dismiss all pending litigation over the biosimilar.
100 
Let's personalize your content